Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

40.76
+4.5712.63%
Post-market: 40.00-0.7600-1.86%19:12 EDT
Volume:3.23M
Turnover:129.69M
Market Cap:3.21B
PE:-8.62
High:40.92
Open:39.40
Low:37.94
Close:36.19
Loading ...

PTC Therapeutics Inc : Jefferies Raises Target Price to $62 From $55

THOMSON REUTERS
·
03 Dec 2024

Sector Update: Health Care Stocks Slipping Late Afternoon

MT Newswires Live
·
03 Dec 2024

Sector Update: Health Care Stocks Softer Monday Afternoon

MT Newswires Live
·
03 Dec 2024

PTC Therapeutics Inks Licensing Pact With Novartis Worth Up To ~$3 Billion For Huntington's Program

Benzinga
·
03 Dec 2024

PTC Therapeutics Strikes Up to $2.9 Billion Licensing Deal With Novartis for Huntington's Disease Drug Candidate

MT Newswires
·
02 Dec 2024

PTC Therapeutics Shares up 15.4% After Co Signs up to $2.9 Billion Licensing Deal With Novartis

THOMSON REUTERS
·
02 Dec 2024

Sector Update: Health Care Stocks Mixed Pre-Bell Monday

MT Newswires Live
·
02 Dec 2024

BUZZ-PTC Therapeutics rises on signing up to $2.9 billion licensing deal with Novartis

Reuters
·
02 Dec 2024

PTC Therapeutics Signs Exclusive Global License Deal With Novartis Unit for PTC518 Huntington's Disease Program; Shares Rise Premarket

MT Newswires Live
·
02 Dec 2024

PTC Therapeutics signs up to $1.9 billion licensing deal with Novartis

Reuters
·
02 Dec 2024

BRIEF-PTC Therapeutics Enters Into A Global License And Collaboration Agreement With Novartis For PTC518 Huntington's Disease Program

Reuters
·
02 Dec 2024

PTC Therapeutics Shares Jump 14.1% Premarket After Agreement With Novartis for Huntington's Disease Program

THOMSON REUTERS
·
02 Dec 2024

PTC Therapeutics Inc - to Receive $1 Billion in Cash at Closing

THOMSON REUTERS
·
02 Dec 2024

PTC Therapeutics Enters Into a Global License and Collaboration Agreement With Novartis for PTC518 Huntington's Disease Program

THOMSON REUTERS
·
02 Dec 2024

PTC Therapeutics Inc - Novartis to Assume Global Development and Commercial Responsibilities

THOMSON REUTERS
·
02 Dec 2024

PTC Therapeutics to sell Priority Review Voucher for $150M

TipRanks
·
28 Nov 2024

RBC Capital Remains a Hold on PTC Therapeutics (PTCT)

TIPRANKS
·
28 Nov 2024

BUZZ-PTC Therapeutics falls after scrapping development of ALS drug

Reuters
·
28 Nov 2024

PTC Therapeutics Ends Utreloxastat Development After Rare Neurodegenerative Disease Trial Misses Goal, Analyst Maintains Outperform With Focus On Sepiapterin, Huntington's Programs

Benzinga
·
27 Nov 2024

TD Cowen Remains a Hold on PTC Therapeutics (PTCT)

TIPRANKS
·
27 Nov 2024